Premarin Tablet, Film Coated
Product Images NDC 0046-1103

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Premarin (NDC 0046-1103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Premarin 01)

A cumulative percent of subjects chart showing percent change from baseline in spine BMD. The graph compares four groups labeled as 0.625, 0.45, 0.3 (likely drug doses), and placebo, with the cumulative percentage plotted on the vertical axis and percent change from baseline on the horizontal axis.*

FDA Label Image

Figure 2 (Premarin 02)

Line graph depicting adjusted percent change from baseline over cycles for Premarin tablets at different dosages (.3 mg, .45 mg, .625 mg) compared to placebo. The x-axis shows the cycle number, and the y-axis shows the percent change from baseline. Data points with error bars represent the different dosage groups and placebo, illustrating trends over time.*

FDA Label Image

Pfizer-logo (Premarin 03)

FDA Label Image

Pfizer Logo (Premarin 04)

FDA Label Image

Principal Display Panel (0.3 MG – LABEL)

Label for Premarin 0.45 mg film-coated tablets, conjugated estrogens, USP, by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label shows the strength as 0.45 mg and the package count of 100 tablets for oral use. Storage instructions and dispensing information are also included.*

FDA Label Image

Principal Display Panel (0.3 MG – CARTON)

Premarin 0.625 mg conjugated estrogens tablets, USP, film-coated oral tablets by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label shows the 1,000 tablet count and indicates storage instructions, dosage form, and child-resistant packaging. Made in Canada.*

FDA Label Image

Principal Display Panel (0.3 MG – BLISTER CARD)

Carton packaging label for Premarin 0.625 mg conjugated estrogens tablets, USP, by Pfizer. The label indicates 1,000 tablets in the package. It includes dosage strength prominently in magenta bars and notes the product is prescription only, dispensed in child-resistant containers, and not for household use. The labeler is Wyeth Pharmaceuticals LLC, a Pfizer subsidiary, with manufacturing in Canada.*

FDA Label Image

Principal Display Panel (0.3 MG)

Premarin 0.625 mg tablets blister card label, containing five film-coated tablets of conjugated estrogens, USP. The label includes a note that it is a professional sample not for sale and is marked Rx only. The labeler is Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.*

FDA Label Image

Principal Display Panel (0.45 MG – LABEL)

Label for Premarin 1.25 mg conjugated estrogens USP tablets, film-coated, oral use. The label includes the Pfizer logo and states the product is distributed by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary, with a package size of 1,000 tablets. Storage instructions and dispensing notes for child-resistant containers are also visible.*

FDA Label Image

Principal Display Panel (0.625 MG – LABEL)

Packaging label for Premarin 1.25 mg conjugated estrogens tablets, USP, by Pfizer. The label indicates the dosage strength as 1.25 mg, the package contains 1,000 film-coated tablets for oral use, and includes dispensing and storage instructions. The label also notes child-resistant container requirements and states it is Rx only.*

FDA Label Image

Principal Display Panel (0.625 MG – BOTTLE CARTON)

Premarin 0.3 mg film-coated tablets, conjugated estrogens oral tablets by Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label shows storage instructions, dispensing notes, quantity of 1,000 tablets, and indicates the product is Rx only. Made in Canada with NDC 0046-1100-91.*

FDA Label Image

Principal Display Panel (0.625 MG)

Premarin 0.3 mg film-coated tablets carton label by Pfizer shows the proprietary name, generic name (conjugated estrogens tablets, USP), strength (0.3 mg), and quantity (1,000 tablets). It includes manufacturer details: Wyeth Pharmaceuticals LLC, a Pfizer subsidiary. The label also notes child-resistant packaging and that it is not for household use.*

FDA Label Image

Principal Display Panel (0.625 MG)

Premarin 0.3 mg (conjugated estrogens tablets, USP) blister card label shows a professional sample not for sale. The label indicates the carton contains five 0.3 mg film-coated tablets. The packaging is identified as a product of Wyeth Pharmaceuticals LLC, a Pfizer subsidiary, with storage instructions and a distinctive oval-shaped tablet description visible.*

FDA Label Image

Principal Display Panel (0.625 MG -CARTON)

Premarin 0.9 mg conjugated estrogens tablets label by Wyeth Pharmaceuticals LLC, a Pfizer Inc. subsidiary. Oral film-coated tablets in a package of 100 tablets. The label includes storage instructions, barcode, NDC number 0046-1103-81, and indicates prescription use only. Made in Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.